Elena Trebinjac
Operationeel Directeur bij Clinical Trials Ontario
Oorsprong van het eerstegraads netwerk van Elena Trebinjac
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Clinical Trials Ontario
Clinical Trials Ontario Miscellaneous Commercial ServicesCommercial Services Clinical Trials Ontario operates as a research and development company for various diseases. The company was founded in 2012 and is headquartered in Toronto, Canada.
10
| Non-Profit Organization | Miscellaneous Commercial Services | 10 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Elena Trebinjac via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Forticell Bioscience, Inc.
Forticell Bioscience, Inc. BiotechnologyHealth Technology Forticell Bioscience, Inc. focuses on advanced regenerative medicine and stem cell therapy. The company was founded in 1991 and is headquartered in Englewood Cliffs, NJ. | Biotechnology | Director/Board Member | |
Notch Therapeutics, Inc.
Notch Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Notch Therapeutics, Inc. engages in the development of cell therapies for the treatment of diseases. It offers technology platform, which uses genetically tailored stem cells as a renewable source for creating allogeneic T cell therapies that expand treatment options and deliver cell immunotherapies to patients. The company was founded by Juan Carlos Zuniga-Pflucker and Peter Zandstra in 2018 and is headquartered in Toronto, Canada. | Pharmaceuticals: Other | Chairman | |
Accel-Rx
Accel-Rx Financial ConglomeratesFinance Accel-Rx provides seed and start-up investment services to the new health sciences companies. It engages in leveraging investment support to the research and commercialization centers such as the existing health-related Centers of Excellence for Commercialization and Research (CECRs). The company was founded by Natalie Dakers in 2014 and is headquartered in Vancouver, Canada. | Financial Conglomerates | Director/Board Member | |
Triphase Accelerator Corp.
Triphase Accelerator Corp. BiotechnologyHealth Technology Triphase Accelerator Corp. develops oncology drug therapeutics. It engages in accelerating oncology products from pre-investigational new drug (pre-IND) to Phase I/Phase II POC. The firm?s product includes Marizomib which is used in cancer treatment. The company is headquartered in Toronto, Canada. | Biotechnology | Chief Executive Officer | |
QD Solar, Inc.
QD Solar, Inc. SemiconductorsElectronic Technology QD Solar, Inc. develops photovoltaic cells using colloidal quantum dot technology in Canada. Its quantum dot technology combines silicon solar cells with infrared solar cells in a hybrid architecture to harvest more of the solar spectrum than silicon alone. The company was founded by Sjoerd Hoogland and Edward Hartley Sargent in 2014 and is headquartered in Toronto, Canada. | Semiconductors | Director/Board Member | |
Centre For Commercialization of Regenerative Medicine
Centre For Commercialization of Regenerative Medicine BiotechnologyHealth Technology Centre For Commercialization of Regenerative Medicine supports our partners to develop and commercialize cell and gene therapies and regenerative medicine technologies. Its services include business, technical and facilities. The company is headquartered in Toronto, Canada. | Biotechnology | Director/Board Member | |
Bedside Clinical Systems, Inc.
Bedside Clinical Systems, Inc. Packaged SoftwareTechnology Services Bedside Clinical Systems, Inc. develops Responses to Illness Severity Quantification (RISQ) framework severity of illness clinical decision support for frontline healthcare professionals, hospital administrators and quality managers. It provides BedsidePEWS, that uses the RISQ framework to empower frontline clinicians who care for hospitalized children. The company was founded by Christopher Parshuram in March 2011 and is headquartered in Toronto, Canada. | Packaged Software | Director/Board Member | |
SCOPUS BIOPHARMA INC. | Pharmaceuticals: Other | Director/Board Member | |
International Genetic Science Partnership | Corporate Officer/Principal | ||
Fibrocor Therapeutics LP
Fibrocor Therapeutics LP Miscellaneous Commercial ServicesCommercial Services Fibrocor Therapeutics LP is a privately held Canadian drug discovery company that is pioneering the use of tissue-specific therapeutics in the field of precision medicine, particularly in fibrosis. The company is based in Toronto, Canada. The company aims to improve the lives of patients by delivering transformative treatments that tackle the root causes of fibrosis, leading to better outcomes and enhanced quality of life. Fibrocor leverages its extensive expertise and one of the largest patient-derived clinically annotated biorepositories of fibrotic tissue to refine and validate therapeutic candidates, ensuring they meet the highest standards of efficacy and safety. | Miscellaneous Commercial Services | Chairman | |
National Institute of Building Sciences
National Institute of Building Sciences Miscellaneous Commercial ServicesCommercial Services National Institute of Building Sciences operates as a non-profit organization. The firm brings together representatives of government, the professions, industry, labor and consumer interests, and regulatory agencies to focus on the identification and resolution of problems and potential problems that hamper the construction of safe, affordable structures for housing, commerce and industry. The company was founded in 1974 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member | |
Cell Cure Neurosciences Ltd.
Cell Cure Neurosciences Ltd. BiotechnologyHealth Technology Cell Cure Neurosciences Ltd. develops cell therapies for neural degenerative diseases. Its therapeutic cells include retinal pigmented epithelial (RPE) cells and neural progenitor cells. The firm's cells are derived from human embryonic stem cells (hESCs), which are considered to be the gold standard source of cells for the development of stem cell therapies. The company was founded in 2005 and is headquartered in Jerusalem, Israel. | Biotechnology | Director/Board Member | |
SOMERO ENTERPRISES, INC. | Trucks/Construction/Farm Machinery | Director/Board Member | |
American Concrete Institute
American Concrete Institute Miscellaneous Commercial ServicesCommercial Services American Concrete Institute operates as an institute for the development of consensus-based standards, technical resources, educational and training programs and certification programs. The company was founded in 1904 and is headquartered in Farmington Hills, MI. | Miscellaneous Commercial Services | President | |
Charles Pankow Foundation | Director/Board Member | ||
GEI Consultants, Inc.
GEI Consultants, Inc. Miscellaneous Commercial ServicesCommercial Services GEI Consultants, Inc. provides engineering, environmental, and ecological consulting services. It also provides geotechnical, water resources, environmental, and ecological science, and engineering consulting services. The company was founded in 1970 and is headquartered in Woburn, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Alpha Corp.
Alpha Corp. Engineering & ConstructionIndustrial Services Alpha Corporation operates as a full-service consulting firm offering a program/construction management, project controls and engineering services to a broad spectrum of clients, including government agencies, municipalities, institutions, private enterprises, developers and contractors. The company is founded in 1979 and is headquartered in Dulles, Virginia. | Engineering & Construction | Director/Board Member | |
AECOM | Engineering & Construction | Corporate Officer/Principal | |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Centre for Probe Development & Commercialization (CPDC) is a leader in the discovery, development, and commercialization of next-generation radiopharmaceuticals. The private company is based in Hamilton, Canada, and was created with the support of multiple stakeholders, including the Networks of Centres of Excellence (NCE), McMaster University, and the Ontario Institute for Cancer Research (OICR). Since its foundation in 2008, CPDC has established a renowned, robust, and reliable platform for the manufacturing and supply of innovative diagnostic and therapeutic radiopharmaceuticals used daily for the detection and treatment of human diseases such as cancer. The Canadian company was founded in 2008 by John Valliant, and the CEO is Bruno Paquin. | Pharmaceuticals: Major | Chairman | |
Ontario Genomics Institute (Private Equity)
Ontario Genomics Institute (Private Equity) Investment ManagersFinance Ontario Genomics Institute (Private Equity) is a Venture Capital firm in UK. The firm was founded in 2001. The firm is headquartered in London. | Investment Managers | Director/Board Member | |
PSYENCE GROUP INC. | Environmental Services | Chief Tech/Sci/R&D Officer | |
Encycle Therapeutics, Inc.
Encycle Therapeutics, Inc. BiotechnologyHealth Technology Encycle Therapeutics, Inc. provides biotechnology services. It offers rapid synthesis of drug-like macrocycles or membrane-permeable nacellins which have enormous potential to target intracellular protein-protein interactions. The company was founded by Andrei Yudin is headquartered in Toronto, Canada. | Biotechnology | Chairman | |
Life Sciences Ontario | Director/Board Member | ||
EVOGENE LTD. | Biotechnology | Director/Board Member | |
Mindsense Biosystems Ltd. | President | ||
Hadasit Medical Research Services & Development Ltd.
Hadasit Medical Research Services & Development Ltd. Miscellaneous Commercial ServicesCommercial Services Hadasit Medical Research Services & Development Ltd. operates as technology transfer company of Hadassah Medical Center in Jerusalem. It identifies, protects, nurtures and commercializes the discoveries made at Hadassah Medical Center. The company's product include Doxil, Periochip, Travelan, Granagard, and Insupad. The company was founded on December 7, 1986 and is headquartered in Jerusalem, Israel. | Miscellaneous Commercial Services | Chief Executive Officer | |
Hadasit Bio-Holdings Ltd. /Private Equity/
Hadasit Bio-Holdings Ltd. /Private Equity/ Investment ManagersFinance Hadasit Bio-Holdings Ltd. /Private Equity/ (Hadasit Bio-Holdings /Private Equity/) is a private equity division of Hadasit Bio-Holdings Ltd. founded in 2005. The firm is headquartered in Jerusalem, Israel. | Investment Managers | Chairman | |
LifeBond Ltd.
LifeBond Ltd. Medical SpecialtiesHealth Technology LifeBond Ltd. engages in the development of medical devices designed to restore and repair tissues to reduce post-operative complications. The company was founded by Nir Mashkif, Orahn Preiss-Bloom and Ishay Attar in 2007 and is headquartered in Caesarea, Israel. | Medical Specialties | Chairman | |
KAHR Medical Ltd.
KAHR Medical Ltd. Pharmaceuticals: MajorHealth Technology KAHR Medical Ltd. develops novel fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. Its drug pipeline is built around the signal converter proteins a unique class of multi-functional therapeutic agents that convert signals sent from one cell to another. The firm?s therapeutic proteins integrate two functional units, enabling each one to elicit multiple cooperative functional endpoints. The company was founded by Mark L. Tykocinski in 2005 and is headquartered in Jerusalem, Israel. | Pharmaceuticals: Major | Chairman | |
Toronto Innovation Acceleration Partners
Toronto Innovation Acceleration Partners BiotechnologyHealth Technology Toronto Innovation operates as a commercialization agent. Its technologies disclosed span therapeutics, medical devices and diagnostic imaging, information and communications technologies, and advanced manufacturing and clean technologies. The company was founded by Raphael Hofstein in June 2009 and is headquartered in Toronto, Canada. | Biotechnology | Chief Executive Officer | |
BIOLINERX LTD. | Pharmaceuticals: Major | Director/Board Member | |
HBL - HADASIT BIO-HOLDINGS LTD | Investment Managers | Chairman | |
Xagenic, Inc.
Xagenic, Inc. Medical SpecialtiesHealth Technology Xagenic, Inc. develops the first lab-free molecular diagnostic platform. Its automated diagnostic platform will enable widespread decentralized testing to be performed outside of clinical laboratories. The firm's amplified redox assay detection technology utilizes electrochemical detection methods and does not rely on optical detection components or enzymatic amplification; crude samples can be analyzed with minimal sample processing. The company was founded by Shana O. Kelley and Edward Hartley Sargent in 2010 and is headquartered in Toronto, Canada. | Medical Specialties | Chief Executive Officer | |
Terheuer Ltd. | Director/Board Member | ||
The Hebrew University of Jerusalem | College/University | Undergraduate Degree | |
Weizmann Institute of Science | College/University | Graduate Degree | |
Bio-MarCare Technologies Ltd.
Bio-MarCare Technologies Ltd. Medical/Nursing ServicesHealth Services Bio-MarCare Technologies Ltd. develops diagnostic kits based on novel biomarkers for early cancer identification, monitoring and assistance. Its product mCRC-Strat is a personalized medicine assay predicting responsiveness to anti EGFR therapy and Colon-MarCarePlex is a molecular assay (qRT-PCR) comprising a panel of RNA markers that can detect the advanced adenoma polyps as well as early stage colorectal cancer. The company was founded by Beatrice Uziely and Rachel Bar-Shavit in 2002 and is headquartered in Jerusalem, Israel. | Medical/Nursing Services | Director/Board Member | |
Dynamic Memory Medical Technologies Ltd. | Director/Board Member | ||
Dying With Dignity Canada | Chairman |
Statistieken
Internationaal
Israël | 21 |
Canada | 17 |
Verenigde Staten | 10 |
Verenigd Koninkrijk | 2 |
Sectoraal
Health Technology | 19 |
Commercial Services | 7 |
Finance | 5 |
Industrial Services | 4 |
Consumer Services | 3 |
Operationeel
Director/Board Member | 39 |
Chairman | 12 |
President | 6 |
Chief Executive Officer | 5 |
Corporate Officer/Principal | 3 |
Sterkste connecties
Insiders | |
---|---|
Raf Hofstein | 36 |
Anne Ellis | 8 |
Mark Lundie | 3 |
Clive Ward-Able | 2 |
Bev Heim-Myers | 2 |
Tina Ceroni | 1 |
James Wilson | 1 |
Susan Marlin | 1 |
Bradly Wouters | 1 |
Kym Boycott | 1 |
- Beurs
- Insiders
- Elena Trebinjac
- Bedrijfsconnecties